[HTML][HTML] Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis

M Liao, Y Li, F Kianifard, E Obi, S Arcona - BMC nephrology, 2016 - Springer
Background Cluster analysis (CA) is a frequently used applied statistical technique that helps
to reveal hidden structures and “clusters” found in large data sets. However, this method …

Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1 …

…, KE Hutchinson, F Donaldson, M Liao… - The Lancet …, 2020 - thelancet.com
Background Atezolizumab is an inhibitor of PD-L1, which can lead to enhanced anticancer T-cell
activity. We aimed to evaluate the safety, pharmacokinetics, and activity of …

Healthcare resource use and direct costs in patients with ankylosing spondylitis and psoriatic arthritis in a large US cohort

…, JB Palmer, Y Li, V Herrera, Y Tsang, M Liao - The Journal of …, 2016 - jrheum.org
Objective. Direct costs of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) have not
been well characterized in the United States. This study assessed healthcare resource use …

[HTML][HTML] Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis

JB Palmer, Y Li, V Herrera, M Liao, M Tran… - BMC musculoskeletal …, 2016 - Springer
Background Real-world data regarding anti-tumor necrosis factor alpha (anti-TNFα) biologic
therapy use in psoriatic arthritis (PsA) are limited; therefore, we described treatment patterns …

Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary …

…, H Jin, J Zhang, X Wang, L Jiang, ML Liao… - Chinese medical …, 2009 - journals.lww.com
Background Current guidelines support primary percutaneous coronary intervention (primary
PCI) as the first treatment of choice (as opposed to thrombolytic therapy) for patients with …

[PDF][PDF] The prognostic value and economic benefits of coronary angiography-derived fractional flow reserve-guided strategy in patients with coronary artery disease

…, Z Lu, L Cai, R Gu, L Shen, Z Xu, W Yao, Y Liu, M Liao… - Heliyon, 2023 - cell.com
Objective This study aims to investigate the prognostic value and economic benefit of
coronary angiography-derived fractional flow reserve (caFFR) guided percutaneous coronary …

Clinical symptoms and self-reported disease severity among patients with psoriasis–implications for psoriasis management

NJ Korman, Y Zhao, Y Li, M Liao… - Journal of Dermatological …, 2015 - Taylor & Francis
Background: Pain, itching, burning and irritation are common symptoms of psoriasis but have
not been well characterized by overall psoriasis severity. Methods: Using 2012 syndicated …

Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation …

…, J Qiu, J Zhang, X Wang, L Jiang, M Liao… - Chinese medical …, 2008 - journals.lww.com
Background Primary percutaneous coronary intervention (PCI) has been identified as the
first therapeutic option for patients with acute ST-segment elevation myocardial infarction (…

Absence of gender disparity in short-term clinical outcomes in patients with acute ST-segment elevation myocardial infarction undergoing sirolimus-eluting stent based …

…, H Jin, JF Zhang, X Wang, L Jiang, M Liao… - Chinese medical …, 2010 - journals.lww.com
Background Randomized, controlled trials have demonstrated the superiority of sirolimus-eluting
stent (SES) implantation during primary percutaneous coronary intervention (PCI), as …

Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar®) in older patients with essential hypertension: Subgroup analysis from the Sevikar …

…, X Han, M Hong, Y Hou, M Liao… - Experimental and …, 2024 - spandidos-publications.com
Essential hypertension is a notable threat for the older (age,≥ 65 years) population.
However, to the best of our knowledge, a real‑world study assessing olmesartan medoxomil‑…